HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jas.2007-0216v1 86/13_suppl/66    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lacasse, P. Articles by Petitclerc, D. Search for Related Content PubMed PubMed Citation Articles by Lacasse, P. Articles by Petitclerc, D.

Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens^1,2

P. Lacasse^*,3, K. Lauzon, M. S. Diarra and D. Petitclerc

^* Agriculture and Agri-Food Canada, Dairy and Swine Research and Development Centre, PO Box 90 STN Lennoxville, Sherbrooke, Quebec, Canada J1M 1Z3; and Crea Biopharma Inc., Sherbrooke, Quebec, Canada; and Agriculture and Agri-Food Canada, Pacific Agri-Food Research Centre, Agassiz, British Columbia, Canada

³ Corresponding author: lacassep{at}agr.gc.ca

The widespread use of antibiotics has lead to the increased presence of pathogens that are less susceptible to their antibacterial effect. Lactoferrin (Lf) is naturally produced by the mammary gland. Lactoferrin is the main whey protein in human milk and is also present in cow’s milk but at a much lower concentration than in human milk. This protein appears to have many biological functions, including antibacterial and antiinflammatory activities. The best-known effect of Lf is to bind iron that is essential for bacterial growth. However, the cationic nature of this protein also appears to be important for the antimicrobial activity of this protein. Lactoferrin has a weak antibacterial effect when used alone, but interestingly, Lf appears much more effective when used at low concentration in combination with several antibiotics. The most striking observation is that Lf increases the inhibitory activity of penicillin up to 4-fold in most penicillin-susceptible Staphylococcus aureus strains, whereas this increase was 4- to 16-fold in penicillin-resistant strains. Indeed, Lf reduces β-lactamase activity in S. aureus strains producing this enzyme. Transcription of β-lactamase gene is dramatically repressed in the presence of Lf. We evaluated the efficacy of intramammary treatments containing penicillin G or bovine Lf (bLf), or both, to cure chronic mastitis caused by a clinical isolate of S. aureus highly resistant to β-lactam antibiotics. In a first trial, mastitis was induced in lactating cows by injecting a low dose of S. aureus through the teat canal of all quarters. Bacterial cure rate was null for control quarters, 11.1% for bLf, 9.1% for penicillin, and 45.5% for the combination of bLf and penicillin. A second trial was undertaken to investigate the effect of an extended therapy on chronic mastitis acquired in a previous lactation. Quarters were treated with 100,000 IU of penicillin G with or without 250 mg of bLf for 7 d. Bacterial cure rate was greater for the bLf + penicillin combination (33.3%) compared with penicillin alone (12.5%). In conclusion, bLf added to penicillin is an effective combination for the treatment of stable S. aureus infections resistant to β-lactam antibiotics.

Key Words: lactoferrin • mastitis • antimicrobial • β-lactamase

This article has been cited by other articles:

				G. E. Dahl The Eighth International Workshop on the Biology of Lactation in Farm Animals: Introduction J Anim Sci, March 1, 2008; 86(13_suppl): 1 - 2. [Full Text] [PDF]